The Efficacy and Safety of Edaravone Dexborneol Sequential Therapy in the Treatment of Patients With AIS

NCT06176781 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

880

Enrollment

OTHER

Sponsor class

Conditions

Subjects With Acute Ischemic Stroke

Interventions

DRUG: Edaravone Dexborneol Sequential Therapy
DRUG: Placebo

Sponsor

Simcere Pharmaceutical Co., Ltd